Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

In reply.

Hawk AF, Chang EY, Shields SM, Simpson KN.

Obstet Gynecol. 2013 Dec;122(6):1306-7. doi: 10.1097/AOG.0000000000000037. No abstract available.

PMID:
24264706
2.

Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis.

Moise KJ Jr.

Obstet Gynecol. 2013 Dec;122(6):1306. doi: 10.1097/AOG.0000000000000036. No abstract available.

PMID:
24264705
3.

Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis.

Hawk AF, Chang EY, Shields SM, Simpson KN.

Obstet Gynecol. 2013 Sep;122(3):579-85. doi: 10.1097/AOG.0b013e31829f8814.

PMID:
23921866
4.

Economics of antenatal prophylaxis.

Cairns JA.

Br J Obstet Gynaecol. 1998 Nov;105 Suppl 18:19-22. Review. No abstract available.

PMID:
9863974
5.

Rho (D) immune globulin i.v. for prevention of Rh isoimmunization and for treatment of ITP.

[No authors listed]

Med Lett Drugs Ther. 1996 Jan 19;38(966):6-8. No abstract available.

PMID:
8544794
6.

Cost matters.

Werner EF.

Obstet Gynecol. 2014 May;123(5):919-20. doi: 10.1097/AOG.0000000000000257. No abstract available.

PMID:
24785839
7.

Rhogam: do midwives hold the evidence?

Wickham S.

Midwifery Today Int Midwife. 1998 Summer;(46):34-5. No abstract available.

PMID:
10338629
9.

More on Rhogam.

Keutzer B.

Midwifery Today Int Midwife. 2000 Winter;(56):68-9; author reply 69. No abstract available.

PMID:
11984911
10.

[Economic analysis of the prevention of anti-D immunization].

Ravinet J, Carbonne B.

J Gynecol Obstet Biol Reprod (Paris). 2006 Feb;35(1 Suppl):1S104-1S111. Review. French.

11.

Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?

Bowman JM.

Am J Obstet Gynecol. 1985 Feb 1;151(3):289-94.

PMID:
2982267
13.

Prevention of Rh(D) alloimmunization: a cost-benefit analysis.

Baskett TF, Parsons ML.

CMAJ. 1990 Feb 15;142(4):337-9.

14.

Anti-D immunoglobulin in RhD prophylaxis.

Robson SC, Lee D, Urbaniak S.

Br J Obstet Gynaecol. 1998 Feb;105(2):129-34. No abstract available.

PMID:
9501773
15.

Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous rho (D) immune globulin.

Sandler SG.

Transfus Med Rev. 2001 Jan;15(1):67-76. Review. No abstract available.

PMID:
11149979
16.

Antenatal suppression of Rh alloimmunization.

Bowman JM.

Clin Obstet Gynecol. 1991 Jun;34(2):296-303. Review.

PMID:
1651184
17.

Rhesus isoimmunization.

Plevyak MP, Carr SR.

Med Health R I. 2001 May;84(5):148-51.

PMID:
11392951
18.

Is Rh immune globulin needed in early first-trimester abortion? A review.

Jabara S, Barnhart KT.

Am J Obstet Gynecol. 2003 Mar;188(3):623-7. Review.

PMID:
12634631
19.

The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.

Chilcott J, Tappenden P, Lloyd Jones M, Wight J, Forman K, Wray J, Beverley C.

BJOG. 2004 Sep;111(9):903-7.

20.

"The use of Rh-immune globulin".

Lavery JP.

Nebr Med J. 1987 May;72(5):175-6. No abstract available.

PMID:
3035388

Supplemental Content

Support Center